
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


UnitedHealth Group Incorporated (UNH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: UNH (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -24.91% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 429.24B USD | Price to earnings Ratio 30.03 | 1Y Target Price 637.24 |
Price to earnings Ratio 30.03 | 1Y Target Price 637.24 | ||
Volume (30-day avg) 4394760 | Beta 0.62 | 52 Weeks Range 431.35 - 628.32 | Updated Date 02/21/2025 |
52 Weeks Range 431.35 - 628.32 | Updated Date 02/21/2025 | ||
Dividends yield (FY) 1.80% | Basic EPS (TTM) 15.53 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.6% | Operating Margin (TTM) 7.71% |
Management Effectiveness
Return on Assets (TTM) 7.06% | Return on Equity (TTM) 15.13% |
Valuation
Trailing PE 30.03 | Forward PE 15.67 | Enterprise Value 477030019064 | Price to Sales(TTM) 1.07 |
Enterprise Value 477030019064 | Price to Sales(TTM) 1.07 | ||
Enterprise Value to Revenue 1.19 | Enterprise Value to EBITDA 16.99 | Shares Outstanding 920284032 | Shares Floating 924534180 |
Shares Outstanding 920284032 | Shares Floating 924534180 | ||
Percent Insiders 0.66 | Percent Institutions 89.68 |
AI Summary
UnitedHealth Group Incorporated: A Comprehensive Overview
This report provides a comprehensive overview of UnitedHealth Group Incorporated (UNH), analyzing its financial performance, market positioning, and growth potential.
Company Profile:
History and Background: UnitedHealth Group (UHG) was established in 1977 as a healthcare insurer. It has grown through acquisitions and organic expansion, becoming a leading diversified healthcare company offering health insurance, care delivery, and technology services.
Core Business Areas: UHG operates through three primary segments:
- UnitedHealthcare: Provides health coverage to over 80 million individuals, including employer-sponsored, individual, Medicare, and Medicaid plans.
- OptumHealth: Delivers care through a network of outpatient facilities, ambulatory surgery centers, and clinics.
- Optum: Offers technology solutions for healthcare providers and payers, including data analytics, pharmacy management, and care coordination platforms.
Leadership and Corporate Structure: Andrew Witty serves as CEO and President, leading a team of executives with extensive experience in healthcare and technology. UHG operates through a decentralized structure with business units focused on specific market segments.
Top Products and Market Share:
Top Products:
- UHC Medicare Advantage Plans: Leading provider of Medicare Advantage plans with over 9 million members.
- UHC Employer-Sponsored Plans: Comprehensive health coverage for over 50 million individuals.
- OptumRx: Pharmacy benefit management services for over 90 million members.
- OptumInsight: Healthcare analytics and data management solutions.
Market Share:
- UHC Employer-Sponsored Plans: Approximately 15% market share in the US.
- OptumRx: Largest pharmacy benefit manager in the US with over 30% market share.
- UHC Medicare Advantage Plans: Second-largest provider with over 14% market share.
Total Addressable Market:
UHG operates in a massive market encompassing:
- Employer-Sponsored Health Insurance: Estimated market size of $1.2 trillion in the US.
- Medicare Advantage: Projected market size of $500 billion by 2030.
- Pharmacy Benefit Management: Expected market size of $700 billion by 2025.
Financial Performance:
Recent Financial Statements:
- Revenue: $324 billion in 2022, representing a 13% year-over-year increase.
- Net Income: $25.7 billion in 2022, reflecting a 10% year-over-year increase.
- Earnings per Share (EPS): $25.81 in 2022, demonstrating a 9% growth compared to the previous year.
- Profit Margin: 7.9% in 2022, indicating a slight improvement from 2021.
- Cash Flow: $24.1 billion in operating cash flow in 2022, demonstrating strong cash generation.
- Balance Sheet: UHG maintains a healthy balance sheet with manageable debt levels.
Dividends and Shareholder Returns:
Dividend History: UNH has a consistent dividend payment history, with an annual dividend of $8.00 per share in 2023. Shareholder Returns: Over the past 5 years, UNH has generated a total shareholder return of 180%, significantly outperforming the S&P 500.
Growth Trajectory:
Historical Growth: UHG has consistently grown revenue and earnings over the past decade, with a compound annual growth rate (CAGR) of 10% for revenue and 12% for EPS.
Future Growth Projections: Analysts project continued growth for UHG, with revenue expected to reach $350 billion by 2025 and EPS reaching $30.
Recent Growth Initiatives:
- Expansion of Medicare Advantage offerings.
- Development of innovative care delivery models.
- Investments in data analytics and technology solutions.
Market Dynamics:
Industry Trends: The healthcare industry is experiencing significant shifts, including:
- Increased focus on value-based care: Healthcare providers are transitioning from fee-for-service to outcome-based payment models.
- Advancement of technology: Healthcare organizations are implementing AI, data analytics, and telehealth to improve efficiency and patient outcomes.
- Consolidation: The healthcare industry is undergoing consolidation, with mergers and acquisitions between major players.
UHG's Positioning: UHG is well-positioned to capitalize on these trends through its integrated business model, focus on value-based care, and investments in technology.
Competitors:
- Anthem (ANTM): Major health insurer with a market share of 10%.
- Cigna (CI): Healthcare provider with a presence in both insurance and pharmacy benefit management.
- Humana (HUM): Leading provider of Medicare Advantage plans.
Competitive Advantages:
- Diversified business model: UHG's integration of health insurance, care delivery, and technology provides a competitive advantage.
- Scale and market share: UHG's size and market share give it significant bargaining power and access to resources.
- Technology capabilities: UHG is a leader in healthcare technology, offering advanced solutions to providers and payers.
Challenges and Opportunities:
Challenges:
- Regulatory environment: The healthcare industry is heavily regulated, which can create challenges for innovation and growth.
- Competition: UHG faces intense competition from other major healthcare providers.
- Cost management: UHG needs to manage rising healthcare costs to maintain profitability.
Opportunities:
- Expansion into new markets: UHG can capitalize on growth opportunities in international markets and emerging segments like behavioral health.
- Continued investment in technology: UHG can leverage technology to further improve efficiency and patient care.
- Strategic partnerships: UHG can pursue strategic partnerships to expand its product offerings and reach new customers.
Recent Acquisitions:
- Change Healthcare (2023): Acquisition of a healthcare technology company providing data analytics and administrative services.
- Equian (2021): Acquisition of a home health and hospice care provider, expanding UHG's care delivery capabilities.
- CareCentrix (2020): Acquisition of a post-acute care management company, strengthening UHG's presence in the post-hospital care market.
These acquisitions align with U
About UnitedHealth Group Incorporated
Exchange NYSE | Headquaters Minnetonka, MN, United States | ||
IPO Launch date 1984-10-26 | CEO & Non-Independent Director Sir Andrew Philip Witty | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees - | |
Full time employees - |
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.